TGF-β/BMP signaling in skeletal biology: molecular mechanisms, regulatory networks, and therapeutic implications in development, regeneration, and disease

Abstract

The transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling pathways are pivotal regulators of cellular processes, playing indispensable roles in embryogenesis, postnatal development, and tissue homeostasis. These pathways are particularly critical within the skeletal system, as they coordinate osteogenesis, chondrogenesis, and bone remodeling through intricate molecular mechanisms. TGF-β/BMP signaling is primarily transduced via canonical Smad-dependent pathways (e.g., ligands, receptors, and intracellular Smads) and the non-canonical Smad-independent (e.g., p38 mitogen-activated protein kinase, MAPK) cascade. Both pathways converge on master transcriptional regulators, including Runx2 and Osterix, and their precise coordination is indispensable for skeletal development, maintenance, and repair. The dysregulation of TGF-β/BMP signaling contributes to a spectrum of skeletal dysplasia and bone pathologies. Advances in molecular genetics, particularly gene-targeting strategies and transgenic mouse models, have deepened our understanding of the spatiotemporal control of TGF-β/BMP signaling in bone and cartilage development. Moreover, emerging research underscores extensive crosstalk between TGF-β/BMP and other critical pathways, such as Wnt/β-catenin, mitogen-activated protein kinase (MAPK), parathyroid hormone (PTH)/PTH-related protein (PTHrP), fibroblast growth factors (FGF), Hedgehog, Notch, insulin-like growth factors (IGF)/insulin-like growth factors receptor (IGFR), Mammalian target of rapamycin (mTOR), and autophagy, forming an integrated regulatory network that ensures skeletal integrity. Our review synthesizes the current knowledge on the molecular components, regulatory mechanisms, and functional integration of TGF-β/BMP signaling in skeletal biology, with an emphasis on its roles in development, regeneration, and disease. By elucidating the molecular underpinnings of TGF-β/BMP pathways and their contextual interactions, we aim to highlight translational opportunities and novel therapeutic strategies for treating skeletal disorders.

References

[1] Soltanoff CS, Yang S, Chen W, Li YP. Signaling networks that control the lineage commitment and differentiation of bone cells. Crit. Rev. Eukaryot. Gene Expr., 2009, 19: 1-46

[2] Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int. J. Biol. Sci., 2012, 8: 272-288

[3] Kamiya N, Mishina Y. New insights on the roles of BMP signaling in bone—a review of recent mouse genetic studies. Biofactors, 2011, 37: 75-82

[4] Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet., 2003, 19: 458-466

[5] Hu S, et al.. Ap-2beta regulates cranial osteogenic potential via the activation of Wnt/beta-catenin signaling pathway. Dev. Biol., 2023, 501: 81-91

[6] Yankee TN, et al.. Integrative analysis of transcriptome dynamics during human craniofacial development identifies candidate disease genes. Nat. Commun., 2023, 14 4623

[7] Chen G, et al.. BMP signaling in the development and regeneration of cranium bones and maintenance of calvarial stem cells. Front. Cell Dev. Biol., 2020, 8: 135

[8] Wu T, Chen G, Tian F, Liu HX. Contribution of cranial neural crest cells to mouse skull development. Int. J. Dev. Biol., 2017, 61: 495-503

[9] Liao J, et al.. Gene regulatory network from cranial neural crest cells to osteoblast differentiation and calvarial bone development. Cell. Mol. Life Sci., 2022, 79: 158

[10] Hu B, et al.. Physiological signatures of dual embryonic origins in mouse skull vault. Cell. Physiol. Biochem., 2017, 43: 2525-2534

[11] Ueharu H, Mishina Y. BMP signaling during craniofacial development: new insights into pathological mechanisms leading to craniofacial anomalies. Front. Physiol., 2023, 14 1170511

[12] Chen G, Yao Y, Xu G, Zhang X. Regional difference in microRNA regulation in the skull vault. Dev. Dyn., 2019, 248: 1009-1019

[13] Chen, G. et al. Specific and spatial labeling of P0-Cre versus Wnt1-Cre in cranial neural crest in early mouse embryos. Genesis55 (2017).

[14] Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer, 2003, 3: 807-821

[15] Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev., 2005, 16: 251-263

[16] Papachroni KK, Karatzas DN, Papavassiliou KA, Basdra EK, Papavassiliou AG. Mechanotransduction in osteoblast regulation and bone disease. Trends Mol. Med., 2009, 15: 208-216

[17] Vlashi R, Zhang X, Li H, Chen G. Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing. Rev. Endocr. Metab. Disord., 2024, 25: 339-367

[18] Ruan X, et al.. IGF signaling pathway in bone and cartilage development, homeostasis, and disease. FASEB J., 2024, 38 e70031

[19] Juma SN, et al.. Osteoarthritis versus psoriasis arthritis: physiopathology, cellular signaling, and therapeutic strategies. Genes Dis., 2024, 11: 100986

[20] Vlashi R, Zhang X, Wu M, Chen G. Wnt signaling: essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. Genes Dis., 2023, 10: 1291-1317

[21] Guo X, Wang XF. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res., 2009, 19: 71-88

[22] Wu M, Chen G, Li YP. TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res., 2016, 4 16009

[23] Costantini A, Guasto A, Cormier-Daire V. TGF-beta and BMP signaling pathways in skeletal dysplasia with short and tall stature. Annu. Rev. Genom. Hum. Genet., 2023, 24: 225-253

[24] Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral. Dis., 2002, 8: 147-159

[25] Urist MR. Bone: formation by autoinduction. Science, 1965, 150: 893-899

[26] Wagner DO, et al.. BMPs: from bone to body morphogenetic proteins. Sci. Signal., 2010, 3: mr1

[27] Yi JJ, Barnes AP, Hand R, Polleux F, Ehlers MD. TGF-beta signaling specifies axons during brain development. Cell, 2010, 142: 144-157

[28] Geiser AG, et al.. A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation. Endocrinology, 2005, 146: 4524-4535

[29] Sanford LP, et al.. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development, 1997, 124: 2659-2670

[30] Dunker N, Krieglstein K. Tgfbeta2^-/- Tgfbeta3^-/- double knockout mice display severe midline fusion defects and early embryonic lethality. Anat. Embryol., 2002, 206: 73-83

[31] Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J. Cell Biol., 1996, 132: 195-210

[32] Guo X, et al.. Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater., 2010, 6: 2920-2931

[33] Yu, Z. et al. TGF-beta prevents the denervation-induced reduction of bone formation and promotes the bone regeneration through inhibiting ubiquitin-proteasome pathway. Biosci. Rep.39, BSR20190350 (2019).

[34] Futrega K, Robey PG, Klein TJ, Crawford RW, Doran MR. A single day of TGF-beta1 exposure activates chondrogenic and hypertrophic differentiation pathways in bone marrow-derived stromal cells. Commun. Biol., 2021, 4: 29

[35] Narcisi R, et al.. beta-1 administration during ex vivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. J. Cell Physiol., 2012, 227: 3282-3290

[36] Suzuki E, et al.. Akt activation is required for TGF-beta1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts. PLoS One, 2014, 9: e112566

[37] Chaverri D, et al.. A pilot study of circulating levels of TGF-beta1 and TGF-beta2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones. Bone Rep., 2022, 16 101157

[38] Cheifetz S, Andres JL, Massague J. The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. J. Biol. Chem., 1988, 263: 16984-16991

[39] Ramachandran, A. et al. TGF-beta uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition. eLife7, e31756 (2018).

[40] Goebel EJ, et al.. CryoEM structure of ALK2:BMP6 reveals distinct mechanism that allow ALK2 to interact with both BMP and activin ligands. Proc. Natl. Acad. Sci. USA, 2025, 122 e2502788122

[41] Mythreye K, Blobe GC. Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion. Cell. Signal., 2009, 21: 1548-1558

[42] Wieteska Ł, et al.. Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling. Nat Commun, 2025, 16: 1-20

[43] Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell, 1993, 73: 1435-1444

[44] Elderbroom JL, et al.. Ectodomain shedding of TbetaRIII is required for TbetaRIII-mediated suppression of TGF-beta signaling and breast cancer migration and invasion. Mol. Biol. Cell, 2014, 25: 2320-2332

[45] Matsunobu T, et al.. Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev. Biol., 2009, 332: 325-338

[46] Houchen CJ, Ghanem S, Kaartinen V, Bumann EE. TGF-β signaling in cranial neural crest affects late-stage mandibular bone resorption and length. Front. Physiol, 2024, 15: 1-11

[47] Zhao H, Oka K, Bringas P, Kaartinen V, Chai Y. TGF-beta type I receptor Alk5 regulates tooth initiation and mandible patterning in a type II receptor-independent manner. Dev. Biol., 2008, 320: 19-29

[48] Almuraikhi N. Inhibition of TGF-beta type I receptor by SB505124 down-regulates osteoblast differentiation and mineralization of human mesenchymal stem cells. Cell Biochem. Funct., 2023, 41: 564-572

[49] Mohammad KS, et al.. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS, 2009, 4: e5275

[50] Toejing, P. et al. Accelerated bone loss in transgenic mice expressing constitutively active TGF-beta receptor type I. Int. J. Mol. Sci.24, 10797 (2023).

[51] Myint, O. et al. Differential gene expression involved in bone turnover of mice expressing constitutively active TGFbeta receptor type I. Int. J. Mol. Sci.25, 5829 (2024).

[52] Seo HS, Serra R. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints. Dev. Biol., 2007, 310: 304-316

[53] Seo HS, Serra R. Tgfbr2 is required for development of the skull vault. Dev. Biol., 2009, 334: 481-490

[54] Longobardi L, et al.. TGF-beta type II receptor/MCP-5 axis: at the crossroad between joint and growth plate development. Dev. Cell, 2012, 23: 71-81

[55] Hosokawa R, et al.. TGF-beta mediated Msx2 expression controls occipital somites-derived caudal region of skull development. Dev. Biol., 2007, 310: 140-153

[56] Iwata J, et al.. Transforming growth factor-beta regulates basal transcriptional regulatory machinery to control cell proliferation and differentiation in cranial neural crest-derived osteoprogenitor cells. J. Biol. Chem., 2010, 285: 4975-4982

[57] Ho TV, et al.. Integration of comprehensive 3D microCT and signaling analysis reveals differential regulatory mechanisms of craniofacial bone development. Dev. Biol., 2015, 400: 180-190

[58] Ito Y, et al.. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development, 2003, 130: 5269-5280

[59] Baffi MO, Moran MA, Serra R. Tgfbr2 regulates the maintenance of boundaries in the axial skeleton. Dev. Biol., 2006, 296: 363-374

[60] Baffi MO, et al.. Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev. Biol., 2004, 276: 124-142

[61] Hiramatsu K, Iwai T, Yoshikawa H, Tsumaki N. Expression of dominant negative TGF-beta receptors inhibits cartilage formation in conditional transgenic mice. J. Bone Min. Metab., 2011, 29: 493-500

[62] Xu C, et al.. TGF-beta receptor II is critical for osteogenic progenitor cell proliferation and differentiation during postnatal alveolar bone formation. Front. Physiol., 2021, 12 721775

[63] Xu C, Xie X, Wu Y, Wang J, Feng JQ. Bone or Tooth dentin: the TGF-beta signaling is the key. Int. J. Biol. Sci., 2024, 20: 3557-3569

[64] Xia C, et al.. TGF-beta/Smad2 signalling regulates enchondral bone formation of Gli1⁺ periosteal cells during fracture healing. Cell Prolif., 2020, 53 e12904

[65] Choi H, et al.. TGF-beta signaling regulates cementum formation through osterix expression. Sci. Rep., 2016, 6 26046

[66] Dole NS, et al.. Osteocyte-intrinsic TGF-beta signaling regulates bone quality through perilacunar/canalicular remodeling. Cell Rep., 2017, 21: 2585-2596

[67] Xu X, et al.. Aberrant activation of TGF-beta in subchondral bone at the onset of rheumatoid arthritis joint destruction. J. Bone, 2015, 30: 2033-2043

[68] Wang W, et al.. Smad2 and Smad3 regulate chondrocyte proliferation and differentiation in the growth plate. PLoS Genet., 2016, 12: e1006352

[69] Weinstein M, et al.. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc. Natl. Acad. Sci. USA, 1998, 95: 9378-9383

[70] Heyer J, et al.. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc. Natl. Acad. Sci. USA, 1999, 96: 12595-12600

[71] Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL, Robertson EJ. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell, 1998, 92: 797-808

[72] Yang X, et al.. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol., 2001, 153: 35-46

[73] Dai G, et al.. Osteocyte TGFbeta1‑Smad2/3 is positively associated with bone turnover parameters in subchondral bone of advanced osteoarthritis. Int. J. Mol. Med., 2020, 46: 167-178

[74] Rothstein M, Azambuja AP, Kanno TY, Breen C, Simoes-Costa M. TGF-beta signaling controls neural crest developmental plasticity via SMAD2/3. Dev. Cell, 2025, 60: 1686-1701.e7

[75] Balooch G, et al.. TGF-beta regulates the mechanical properties and composition of bone matrix. Proc. Natl. Acad. Sci. USA, 2005, 102: 18813-18818

[76] Tan X, et al.. Smad4 is required for maintaining normal murine postnatal bone homeostasis. J. Cell Sci., 2007, 120: 2162-2170

[77] Jones JB, Kern SE. Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4. Nucleic Acids Res., 2000, 28: 2363-2368

[78] Li C, Li YP, Fu XY, Deng CX. Anterior visceral endoderm SMAD4 signaling specifies anterior embryonic patterning and head induction in mice. Int. J. Biol. Sci., 2010, 6: 569-583

[79] Yan J, et al.. Smad4 deficiency impairs chondrocyte hypertrophy via the Runx2 transcription factor in mouse skeletal development. J. Biol. Chem., 2018, 293: 9162-9175

[80] Krambs JR, Abou Ezzi G, Yao JC, Link DC. Canonical signaling by TGF family members in mesenchymal stromal cells is dispensable for hematopoietic niche maintenance under basal and stress conditions. PLoS, 2020, 15: e0233751

[81] Ko SO, et al.. Smad4 is required to regulate the fate of cranial neural crest cells. Dev. Biol., 2007, 312: 435-447

[82] Zhang J, et al.. Smad4 is required for the normal organization of the cartilage growth plate. Dev. Biol., 2005, 284: 311-322

[83] Greenblatt MB, et al.. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin., 2010, 120: 2457-2473

[84] Matsuguchi T, et al.. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation. J. Bone, 2009, 24: 398-410

[85] Ulici V, et al.. The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone, 2009, 45: 1133-1145

[86] Yumoto K, et al.. TGF-beta-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells. J. Biol. Chem., 2013, 288: 13467-13480

[87] van Caam A, et al.. TGFbeta1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity. Arthritis Res. Ther., 2017, 19: 112

[88] Yasui T, et al.. Regulation of RANKL-induced osteoclastogenesis by TGF-beta through molecular interaction between Smad3 and Traf6. J. Bone, 2011, 26: 1447-1456

[89] Lee KS, Hong SH, Bae SC. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene, 2002, 21: 7156-7163

[90] Wang TH, Watanabe K, Hamada N, Tani-Ishii N. Role of MAPKs in TGF-beta1-induced maturation and mineralization in human osteoblast-like cells. J. Oral Biosci., 2024, 66: 61-67

[91] Lee SW, et al.. TGF-beta2 stimulates cranial suture closure through activation of the Erk-MAPK pathway. J. Cell. Biochem., 2006, 98: 981-991

[92] Lai CF, Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J. Biol. Chem., 2002, 277: 15514-15522

[93] Coricor G, Serra R. TGF-beta regulates phosphorylation and stabilization of Sox9 protein in chondrocytes through p38 and Smad dependent mechanisms. Sci. Rep., 2016, 6 38616

[94] Xu X, et al.. Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-beta/BMP signaling during tooth and palate development. Dev. Cell, 2008, 15: 322-329

[95] Kim SI, et al.. TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am. J. Physiol. Ren. Physiol., 2007, 292: F1471-1478

[96] Cibi, D. M. et al. Neural crest-specific deletion of Rbfox2 in mice leads to craniofacial abnormalities including cleft palate. eLife8, e45418 (2019).

[97] McCarthy TL, Centrella M. Novel links among Wnt and TGF-beta signaling and Runx2. Mol. Endocrinol., 2010, 24: 587-597

[98] Zhou S, Eid K, Glowacki J. Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. J. Bone, 2004, 19: 463-470

[99] Zhou S. TGF-beta regulates beta-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J. Cell. Biochem., 2011, 112: 1651-1660

[100] Dong Y, et al.. Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta. J. Cell. Biochem., 2005, 95: 1057-1068

[101] Dao DY, Yang X, Chen D, Zuscik M, O’Keefe RJ. Axin1 and Axin2 are regulated by TGF- and mediate cross-talk between TGF- and Wnt signaling pathways. Ann. N. Y. Acad. Sci., 2007, 1116: 82-99

[102] Weivoda MM, et al.. Osteoclast TGF-beta receptor signaling induces Wnt1 secretion and couples bone resorption to bone formation. J. Bone Min. Res., 2016, 31: 76-85

[103] Hiyama A, et al.. The relationship between the Wnt/beta-catenin and TGF-beta/BMP signals in the intervertebral disc cell. J. Cell. Physiol., 2011, 226: 1139-1148

[104] Swartz ME, Eberhart JK. Facing up to your potential: neural crest under the influence of TGF-beta. Dev. Cell, 2025, 60: 1657-1659

[105] Suva LJ, Friedman PA. Structural pharmacology of PTH and PTHrP. Vitam. Horm., 2022, 120: 1-21

[106] White AD, et al.. Spatial bias in cAMP generation determines biological responses to PTH type 1 receptor activation. Sci. Signal., 2021, 14 eabc5944

[107] Martin TJ, Sims NA, Seeman E. Physiological and Pharmacological Roles of PTH and PTHrP in bone using their shared receptor, PTH1R. Endocr. Rev., 2021, 42: 383-406

[108] Suva LJ, Friedman PA. PTH and PTHrP actions on bone. Handb. Exp. Pharmacol., 2020, 262: 27-45

[109] Leong I. Effects of PTH on bone composition. Nat. Rev. Endocrinol., 2018, 14: 689

[110] Atfi A, Baron R. PTH battles TGF-beta in bone. Nat. Cell Biol., 2010, 12: 205-207

[111] Qiu T, et al.. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Nat. Cell Biol., 2010, 12: 224-234

[112] Zhang R, et al.. Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts. PLoS, 2011, 6: e20780

[113] Siddiqui JA, et al.. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone’s anabolic actions in bone implicates TGF-beta signaling. Bone, 2021, 143 115762

[114] Crane JL, Cao X. Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling. J. Clin., 2014, 124: 466-472

[115] Dutra EH, et al.. FGF ligands and receptors in osteochondral tissues of the temporomandibular joint in young and aging mice. Cartilage, 2024, 15: 195-199

[116] Bobzin L, et al.. FGFR2 directs inhibition of WNT signaling to regulateanterior fontanelle closure during skull development. Development, 2025, 152: dev204264

[117] Murugaiyan, K., Amirthalingam, S., Hwang, N. S. & Jayakumar, R. Role of FGF-18 in bone regeneration. J. Funct. Biomater.14, 36 (2023).

[118] Bosetti M, Boccafoschi F, Leigheb M, Cannas MF. Effect of different growth factors on human osteoblasts activities: a possible application in bone regeneration for tissue engineering. Biomol. Eng., 2007, 24: 613-618

[119] Yabe M, et al.. Synergistic effect of FGF-2 and TGF-beta1 on the mineralization of human umbilical cord perivascular cells. Arch. Oral Biol., 2023, 156 105826

[120] Bakhshayesh M, Soleimani M, Mehdizadeh M, Katebi M. Effects of TGF-beta and b-FGF on the potential of peripheral blood-borne stem cells and bone marrow-derived stem cells in wound healing in a murine model. Inflammation, 2012, 35: 138-142

[121] Romero R, et al.. Combined delivery of FGF-2, TGF-beta1, and adipose-derived stem cells from an engineered periosteum to a critical-sized mouse femur defect. J. Biomed. Mater. Res. A, 2017, 105: 900-911

[122] Wen X, et al.. Chondrocyte FGFR3 regulates bone mass by inhibiting osteogenesis. J. Biol. Chem., 2016, 291: 24912-24921

[123] Hildner F, et al.. FGF-2 abolishes the chondrogenic effect of combined BMP-6 and TGF-beta in human adipose derived stem cells. J. Biomed. Mater. Res. A, 2010, 94: 978-987

[124] Gosain AK, Recinos RF, Agresti M, Khanna AK. TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures. Plast. Reconstr. Surg., 2004, 113: 1675-1684

[125] Sasaki T, et al.. TGFbeta-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development. Development, 2006, 133: 371-381

[126] Mukherjee A, Dong SS, Clemens T, Alvarez J, Serra R. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures. Mech. Dev., 2005, 122: 557-571

[127] Wang J, et al.. Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc. Natl. Acad. Sci. USA, 2023, 120 e2203779120

[128] Svensson, J. et al. Bone-derived IGF-I regulates radial bone growth in adult male mice. Endocrinology164, bqad104 (2023).

[129] Nagao, H. et al. Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains. Proc. Natl. Acad. Sci. USA118, e2019474118 (2021).

[130] Racine HL, Serrat MA. The actions of IGF-1 in the growth plate and its role in postnatal bone elongation. Curr. Osteoporos. Rep., 2020, 18: 210-227

[131] Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone, 1996, 19: 1S-12S

[132] Longobardi L, et al.. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J. Bone Min. Res., 2006, 21: 626-636

[133] Morscheid, S., Venkatesan, J. K., Rey-Rico, A., Schmitt, G. & Cucchiarini, M. Remodeling of human osteochondral defects via rAAV-mediated co-overexpression of TGF-beta and IGF-I from implanted human bone marrow-derived mesenchymal stromal cells. J. Clin. Med.8, 1326 (2019).

[134] Leem KH, et al.. Hydrolyzed collagen tripeptide promotes longitudinal bone growth in childhood rats via increases in insulin-like growth factor-1 and bone morphogenetic proteins. J. Med. Food, 2023, 26: 809-819

[135] Asparuhova, M. B. et al. Local concentrations of TGF-beta1 and IGF-1 appear determinant in regulating bone regeneration in human postextraction tooth sockets. Int. J. Mol. Sci.24, 8239 (2023).

[136] Singhatanadgit W, Salih V, Olsen I. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions. J. Cell. Physiol., 2006, 209: 912-922

[137] Zhang Y, et al.. Analysis and characterization of the functional TGFbeta receptors required for BMP6-induced osteogenic differentiation of mesenchymal progenitor cells. BMB Rep., 2013, 46: 107-112

[138] Tachi K, et al.. Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-beta1. Tissue Eng. Part A, 2011, 17: 597-606

[139] Wu N, Zhao Y, Yin Y, Zhang Y, Luo J. Identification and analysis of type II TGF-beta receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. Acta Biochim. Biophys. Sin., 2010, 42: 699-708

[140] Yuan G, Zhan Y, Gou X, Chen Y, Yang G. TGF-beta signaling inhibits canonical BMP signaling pathway during palate development. Cell Tissue Res., 2018, 371: 283-291

[141] Collu GM, Mlodzik M. The beauty of seeing the real thing: BMP heterodimer detection in vivo reveals dimer composition and activity. Dev. Cell, 2023, 58: 633-634

[142] Riaz Z, et al.. In silico analysis: genome-wide identification, characterization and evolutionary adaptations of bone morphogenetic protein (BMP) gene family in Homo sapiens. Mol. Biotechnol., 2024, 66: 3336-3356

[143] Graf D, Malik Z, Hayano S, Mishina Y. Common mechanisms in development and disease: BMP signaling in craniofacial development. Cytokine Growth Factor Rev., 2016, 27: 129-139

[144] Huang Z, Ren PG, Ma T, Smith RL, Goodman SB. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine, 2010, 51: 305-310

[145] Noel D, et al.. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells, 2004, 22: 74-85

[146] Tsuji K, et al.. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet., 2006, 38: 1424-1429

[147] Feng W, Chen N, Chen K, Chen T. Forkhead box O-1 regulates the biological behavior of BMP-2-induced human bone mesenchymal stem cells through mitochondrial dynamics and autophagy. Biomol. Biomed., 2025, 25: 869-882

[148] Gorlitz S, et al.. Temporal regulation of BMP2 growth factor signaling in response to mechanical loading is linked to cytoskeletal and focal adhesion remodeling. Commun. Biol., 2024, 7: 1064

[149] Guimond JC, et al.. BMP-2 functions independently of SHH signaling and triggers cell condensation and apoptosis in regenerating axolotl limbs. BMC Dev. Biol., 2010, 10: 15

[150] Chen Y, Wang Z, Chen Y, Zhang Y. Conditional deletion of Bmp2 in cranial neural crest cells recapitulates Pierre Robin sequence in mice. Cell Tissue Res., 2019, 376: 199-210

[151] Shah, T. A. et al. Characterization of new bone morphogenetic protein (Bmp)-2 regulatory alleles. Genesis55 (2017).

[152] Hwang JW, Han YH. Novel bone morphogenetic protein (BMP)-2/4 consensus peptide (BCP) for the osteogenic differentiation of C2C12 cells. Curr. Protein Pept. Sci., 2023, 24: 610-619

[153] Gu K, Zhang L, Jin T, Rutherford RB. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Cells Tissues Organs, 2004, 176: 28-40

[154] Shen B, et al.. The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J. Cell. Biochem., 2010, 109: 406-416

[155] Tsuji K, et al.. Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair. J. Orthop. Res., 2010, 28: 384-389

[156] Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM. The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development, 2000, 127: 621-630

[157] Tsuji K, et al.. BMP4 is dispensable for skeletogenesis and fracture-healing in the limb. J. Bone Jt. Surg. Am., 2008, 90: 14-18

[158] Shu B, et al.. BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J. Cell Sci., 2011, 124: 3428-3440

[159] Albertson RC, Streelman JT, Kocher TD, Yelick PC. Integration and evolution of the cichlid mandible: the molecular basis of alternate feeding strategies. Proc. Natl. Acad. Sci. USA, 2005, 102: 16287-16292

[160] Suzuki K, et al.. Reduced BMP signaling results in hindlimb fusion with lethal pelvic/urogenital organ aplasia: a new mouse model of sirenomelia. PLoS, 2012, 7: e43453

[161] Liu W, et al.. Distinct functions for Bmp signaling in lip and palate fusion in mice. Development, 2005, 132: 1453-1461

[162] Bandyopadhyay A, et al.. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet., 2006, 2: e216

[163] Tischfield MA, et al.. Cerebral vein malformations result from loss of Twist1 expression and BMP signaling from skull progenitor cells and dura. Dev. Cell, 2017, 42: 445-461.e5

[164] Daluiski A, et al.. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet., 2001, 27: 84-88

[165] Gamer LW, Ho V, Cox K, Rosen V. Expression and function of BMP3 during chick limb development. Dev. Dyn., 2008, 237: 1691-1698

[166] Kokabu S, et al.. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol., 2012, 26: 87-94

[167] Gamer LW, Cox K, Carlo JM, Rosen V. Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures. Dev. Dyn., 2009, 238: 2374-2381

[168] Matsumoto Y, et al.. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Mol. Cell. Endocrinol., 2012, 350: 78-86

[169] Kodama N, et al.. BMP3b regulates bone mass by inhibiting BMP signaling. Bone, 2025, 190 117303

[170] Lu Q, et al.. GDF11 inhibits bone formation by activating Smad2/3 in bone marrow mesenchymal stem cells. Calcif. Tissue Int., 2016, 99: 500-509

[171] Clendenning DE, Mortlock DP. The BMP ligand Gdf6 prevents differentiation of coronal suture mesenchyme in early cranial development. PLoS, 2012, 7: e36789

[172] Su CJ, et al.. Ligand-receptor promiscuity enables cellular addressing. Cell Syst., 2022, 13: 408-425.e12

[173] Klumpe HE, et al.. The context-dependent, combinatorial logic of BMP signaling. Cell Syst., 2022, 13: 388-407.e10

[174] Jatzlau J, et al.. A versatile Halo- and SNAP-tagged BMP/TGFbeta receptor library for quantification of cell surface ligand binding. Commun. Biol., 2023, 6: 34

[175] Komorowski M. Making sense of BMP signaling complexity. Cell Syst., 2022, 13: 349-351

[176] Mast JF, Leach EAE, Thompson TB. Characterization of erythroferrone oligomerization and its impact on BMP antagonism. J. Biol. Chem., 2024, 300 105452

[177] Gomez-Puerto MC, Iyengar PV, Garcia de Vinuesa A, Ten Dijke P, Sanchez-Duffhues G. Bone morphogenetic protein receptor signal transduction in human disease. J. Pathol., 2019, 247: 9-20

[178] Nickel J, Dreyer MK, Kirsch T, Sebald W. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists. J. Bone Jt. Surg. Am., 2001, 83(A Suppl 1): S7-14

[179] Kudo TA, et al.. Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II. Tohoku J. Exp. Med., 2010, 222: 121-129

[180] Liu H, Zhang R, Chen D, Oyajobi BO, Zhao M. Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation. J. Cell. Physiol., 2012, 227: 952-963

[181] Gamer LW, et al.. BMPR-II is dispensable for formation of the limb skeleton. Genesis, 2011, 49: 719-724

[182] Pearsall RS, et al.. A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc. Natl. Acad. Sci. USA, 2008, 105: 7082-7087

[183] Puolakkainen T, et al.. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy. BMC Musculoskelet. Disord., 2017, 18 20

[184] Puolakkainen T, et al.. Treatment with soluble activin type IIB receptor ameliorates ovariectomy-induced bone loss and fat gain in mice. Calcif. Tissue Int., 2022, 110: 504-517

[185] Shore EM, et al.. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet., 2006, 38: 525-527

[186] Chakkalakal SA, et al.. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J. Bone, 2012, 27: 1746-1756

[187] Yang J, et al.. A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice. Bone, 2025, 199 117565

[188] Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech. Dev., 2004, 121: 173-182

[189] Towler OW, Peck SH, Kaplan FS, Shore EM. Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP). Dev. Biol., 2021, 470: 136-146

[190] Culbert AL, et al.. Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. Stem Cells, 2014, 32: 1289-1300

[191] Fukuda T, et al.. Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2. Genesis, 2006, 44: 159-167

[192] Yang, J. et al. Augmented BMP signaling commits cranial neural crest cells to a chondrogenic fate by suppressing autophagic beta-catenin degradation. Sci. Signal.14, eaaz9368 (2021).

[193] Yang J, et al.. A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis. J. Clin. Invest., 2024, 134: e165787

[194] Yamaguchi H, Swaminathan S, Mishina Y, Komatsu Y. Enhanced BMP signaling leads to enlarged nasal cartilage formation in mice. Biochem. Biophys. Res. Commun., 2023, 678: 173-178

[195] Agarwal S, et al.. BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints. Dev. Biol., 2015, 400: 202-209

[196] Omi M, Kaartinen V, Mishina Y. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway. J. Biol. Chem., 2019, 294: 17818-17836

[197] Yamaguchi H, et al.. Enhanced BMP signaling via ALK2 in osteoclasts decreases bone density in mice. Biochem. Biophys. Res. Commun., 2025, 777 152260

[198] Yang J, et al.. Generation of a new mouse line with conditionally activated signaling through the BMP receptor, ACVR1: a tool to characterize pleiotropic roles of BMP functions. Genesis, 2021, 59 e23419

[199] Keum BR, et al.. Transmembrane protein 150b attenuates BMP signaling in the Xenopus organizer. J. Cell. Physiol., 2023, 238: 1850-1866

[200] Stottmann RW, Klingensmith J. Bone morphogenetic protein signaling is required in the dorsal neural folds before neurulation for the induction of spinal neural crest cells and dorsal neurons. Dev. Dyn., 2011, 240: 755-765

[201] Komatsu Y, et al.. Augmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice. J. Bone, 2013, 28: 1422-1433

[202] Ovchinnikov DA, et al.. BMP receptor type IA in limb bud mesenchyme regulates distal outgrowth and patterning. Dev. Biol., 2006, 295: 103-115

[203] Yang, R. et al. BMP signaling maintains auricular chondrocyte identity and prevents microtia development by inhibiting protein kinase A. eLife12, RP91883 (2024).

[204] Pan H, et al.. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development. Dev. Biol., 2017, 429: 260-270

[205] He G, et al.. Differential involvement of Wnt signaling in Bmp regulation of cancellous versus periosteal bone growth. Bone Res., 2017, 5 17016

[206] Rountree RB, et al.. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol., 2004, 2: e355

[207] Feng J, et al.. BMP signaling orchestrates a transcriptional network to control the fate of mesenchymal stem cells in mice. Development, 2017, 144: 2560-2569

[208] Li N, et al.. Altered BMP-Smad4 signaling causes complete cleft palate by disturbing osteogenesis in palatal mesenchyme. J. Mol. Histol., 2021, 52: 45-61

[209] Okamoto M, et al.. Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice. J. Bone, 2011, 26: 2511-2522

[210] Mishina Y, et al.. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J. Biol. Chem., 2004, 279: 27560-27566

[211] Kamiya N, et al.. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J. Bone, 2008, 23: 2007-2017

[212] Omi M, et al.. Increased BMP-Smad signaling does not affect net bone mass in long bones. Front. Physiol., 2023, 14 1145763

[213] Saito H, Yamamura K, Suzuki N. Reduced bone morphogenetic protein receptor type 1A signaling in neural-crest-derived cells causes facial dysmorphism. Dis. Models Mech., 2012, 5: 948-955

[214] Gu S, et al.. BMPRIA mediated signaling is essential for temporomandibular joint development in mice. PLoS, 2014, 9: e101000

[215] Kramer K, et al.. Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model. Genesis, 2018, 56 e23220

[216] Hayano S, Komatsu Y, Pan H, Mishina Y. Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis. Development, 2015, 142: 1357-1367

[217] Haaijman A, et al.. Correlation between ALK-6 (BMPR-IB) distribution and responsiveness to osteogenic protein-1 (BMP-7) in embryonic mouse bone rudiments. Growth Factors, 2000, 17: 177-192

[218] Singhatanadgit W, Olsen I. Endogenous BMPR-IB signaling is required for early osteoblast differentiation of human bone cells. In Vitro Cell. Dev. Biol. Anim., 2011, 47: 251-259

[219] Singhatanadgit W, Salih V, Olsen I. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells. Cell Biol. Int., 2008, 32: 1362-1370

[220] Wang Y, et al.. Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. Connect. Tissue Res., 2012, 53: 528-534

[221] Lee HK, et al.. Odontogenic ameloblasts-associated protein (ODAM), via phosphorylation by bone morphogenetic protein receptor type IB (BMPR-IB), is implicated in ameloblast differentiation. J. Cell. Biochem., 2012, 113: 1754-1765

[222] Rigueur D, et al.. The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. J. Bone, 2015, 30: 733-741

[223] Yamawaki K, et al.. The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders. Sci. Rep., 2016, 6 18849

[224] Fuentealba LC, et al.. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell, 2007, 131: 980-993

[225] Skarzynska J, et al.. Modification of Smad1 linker modulates BMP-mediated osteogenesis of adult human MSC. Connect. Tissue Res., 2011, 52: 408-414

[226] Zhou Z, et al.. Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation. Dev. Cell, 2010, 19: 90-102

[227] Podkowa M, Attisano L. A skeleton in the closet: neogenin guides bone development. Dev. Cell, 2010, 19: 1-2

[228] Wang M, et al.. Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthr. Cartil., 2011, 19: 751-762

[229] Retting KN, Song B, Yoon BS, Lyons KM. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development, 2009, 136: 1093-1104

[230] Gregson CL, et al.. A rare mutation in SMAD9 associated with high bone mass identifies the SMAD-dependent BMP signaling pathway as a potential anabolic target for osteoporosis. J. Bone, 2020, 35: 92-105

[231] Nie X, Deng CX, Wang Q, Jiao K. Disruption of Smad4 in neural crest cells leads to mid-gestation death with pharyngeal arch, craniofacial and cardiac defects. Dev. Biol., 2008, 316: 417-430

[232] Wrana JL. The secret life of Smad4. Cell, 2009, 136: 13-14

[233] Dupont S, et al.. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell, 2009, 136: 123-135

[234] Kang M, Bok J, Deocaris CC, Park HW, Kim MH. Hoxc8 represses BMP-induced expression of Smad6. Mol. Cells, 2010, 29: 29-33

[235] Estrada KD, Retting KN, Chin AM, Lyons KM. Smad6 is essential to limit BMP signaling during cartilage development. J. Bone, 2011, 26: 2498-2510

[236] Timberlake AT, et al.. Co-occurrence of frameshift mutations in SMAD6 and TCF12 in a child with complex craniosynostosis. Hum. Genome Var., 2018, 5: 14

[237] Hoffmann A, et al.. Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors. J. Biol. Chem., 2005, 280: 27271-27283

[238] Greenblatt MB, Shim JH, Glimcher LH. TAK1 mediates BMP signaling in cartilage. Ann. N. Y. Acad. Sci., 2010, 1192: 385-390

[239] Zuzarte-Luis V, et al.. A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev. Biol., 2004, 272: 39-52

[240] Afzal F, et al.. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J. Cell. Physiol., 2005, 204: 63-72

[241] Lee KS, et al.. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol., 2000, 20: 8783-8792

[242] Takarada T, et al.. An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. J. Bone, 2013, 28: 2064-2069

[243] Rashid H, Smith CM, Convers V, Clark K, Javed A. Runx2 deletion in hypertrophic chondrocytes impairs osteoclast mediated bone resorption. Bone, 2024, 181 117014

[244] Qin X, et al.. Runt-related transcription factor-2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice. J. Bone, 2021, 36: 2081-2095

[245] Takarada T, et al.. Genetic analysis of Runx2 function during intramembranous ossification. Development, 2016, 143: 211-218

[246] Qin X, Jiang Q, Miyazaki T, Komori T. Runx2 regulates cranial suture closure by inducing hedgehog, Fgf, Wnt and Pthlh signaling pathway gene expressions in suture mesenchymal cells. Hum. Mol. Genet., 2019, 28: 896-911

[247] Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone, 2006, 21: 637-646

[248] Javed A, et al.. Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs, 2009, 189: 133-137

[249] Jonason JH, Xiao G, Zhang M, Xing L, Chen D. Post-translational regulation of Runx2 in bone and cartilage. J. Dent. Res., 2009, 88: 693-703

[250] Zhang YW, et al.. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA, 2000, 97: 10549-10554

[251] Holleville N, Mateos S, Bontoux M, Bollerot K, Monsoro-Burq AH. Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme. Dev. Biol., 2007, 304: 860-874

[252] Kawane T, et al.. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression. J. Bone, 2014, 29: 1960-1969

[253] Zhang C. Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J. Orthop. Surg. Res., 2010, 5: 37

[254] Baek WY, et al.. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J. Bone, 2009, 24: 1055-1065

[255] Baek WY, Kim YJ, de Crombrugghe B, Kim JE. Osterix is required for cranial neural crest-derived craniofacial bone formation. Biochem. Biophys. Res. Commun., 2013, 432: 188-192

[256] Baek WY, de Crombrugghe B, Kim JE. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Bone, 2010, 46: 920-928

[257] Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun., 2003, 309: 689-694

[258] Jeong HM, et al.. Akt phosphorylates and regulates the function of Dlx5. Biochem. Biophys. Res. Commun., 2011, 409: 681-686

[259] Choi YH, et al.. Akt phosphorylates and regulates the osteogenic activity of Osterix. Biochem. Biophys. Res. Commun., 2011, 411: 637-641

[260] Zhang M, et al.. BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J. Cell. Biochem., 2009, 108: 896-905

[261] Tang N, et al.. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J. Cell. Mol. Med., 2009, 13: 2448-2464

[262] Yan Y, et al.. Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J. Cell Sci., 2009, 122: 3566-3578

[263] Kamiya N, et al.. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development, 2008, 135: 3801-3811

[264] Song D, He G, Shi Y, Ni J, Long F. Functional interaction between Wnt and Bmp signaling in periosteal bone growth. Sci. Rep., 2021, 11 10782

[265] Kamiya N, et al.. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J. Bone, 2010, 25: 200-210

[266] Kamiya N. The role of BMPs in bone anabolism and their potential targets SOST and DKK1. Curr Mol. Pharmacol, 2012, 5: 153-163

[267] Ionescu AM, et al.. CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter. J. Cell. Physiol., 2004, 198: 428-440

[268] Zhao L, et al.. Downregulation of cAMP-dependent protein kinase inhibitor gamma is required for BMP-2-induced osteoblastic differentiation. Int. J. Biochem. Cell Biol., 2006, 38: 2064-2073

[269] Morita M, et al.. Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models. Proc. Natl. Acad. Sci. USA, 2023, 120 e2213317120

[270] Ohta Y, et al.. Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway. J. Bone, 2008, 26: 478-484

[271] Fakhry A, et al.. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone, 2005, 36: 254-266

[272] Gromolak, S. et al. Biological characteristics and osteogenic differentiation of ovine bone marrow derived mesenchymal stem cells stimulated with FGF-2 and BMP-2. Int. J. Mol. Sci.21, 9726 (2020).

[273] Naganawa T, et al.. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J. Cell. Biochem., 2008, 103: 1975-1988

[274] Parsegian K. The BMP and FGF pathways reciprocally regulate odontoblast differentiation. Connect. Tissue Res., 2023, 64: 53-63

[275] Choi KY, et al.. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev. Dyn., 2005, 233: 115-121

[276] Rambhia, K. J. et al. Nanofibrous 3D scaffolds capable of individually controlled BMP and FGF release for the regulation of bone regeneration. Acta Biomater.190, 50–63 (2024).

[277] Hughes-Fulford M, Li CF. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J. Orthop. Surg. Res., 2011, 6: 8

[278] Yin J, et al.. Controlled release of FGF-2 and BMP-2 in tissue engineered periosteum promotes bone repair in rats. Biomed. Mater., 2018, 13: 025001

[279] Oortgiesen DA, Walboomers XF, Bronckers AL, Meijer GJ, Jansen JA. Periodontal regeneration using an injectable bone cement combined with BMP-2 or FGF-2. J. Tissue Eng. Regen. Med., 2014, 8: 202-209

[280] Kuhn LT, Peng T, Gronowicz G, Hurley MM. Endogenous FGF-2 levels impact FGF-2/BMP-2 growth factor delivery dosing in aged murine calvarial bone defects. J. Biomed. Mater. Res. A, 2021, 109: 2545-2555

[281] Qi H, et al.. FGFR3 induces degradation of BMP type I receptor to regulate skeletal development. Biochim. Biophys. Acta, 2014, 1843: 1237-1247

[282] Nakamura Y, et al.. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone, 2005, 36: 399-407

[283] Ballhause, T. M. et al. Relevance of Notch signaling for bone metabolism and regeneration. Int. J. Mol. Sci.22, 1325 (2021).

[284] Tezuka K, et al.. Stimulation of osteoblastic cell differentiation by Notch. J. Bone, 2002, 17: 231-239

[285] Nobta M, et al.. Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J. Biol. Chem., 2005, 280: 15842-15848

[286] Seong CH, et al.. Bone morphogenetic protein 9 (BMP9) directly induces Notch effector molecule Hes1 through the SMAD signaling pathway in osteoblasts. FEBS Lett., 2021, 595: 389-403

[287] de Jong DS, et al.. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochem. Biophys. Res. Commun., 2004, 320: 100-107

[288] Dahlqvist C, et al.. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development, 2003, 130: 6089-6099

[289] Minamizato T, et al.. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways. Biochem. Biophys. Res. Commun., 2007, 354: 567-573

[290] Wagley Y, et al.. Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation. Stem Cells, 2020, 38: 1332-1347

[291] Deregowski V, Gazzerro E, Priest L, Rydziel S, Canalis E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J. Biol. Chem., 2006, 281: 6203-6210

[292] Hojo H, Ohba S, Chung UI. Signaling pathways regulating the specification and differentiation of the osteoblast lineage. Regen. Ther., 2015, 1: 57-62

[293] Ohba, S. Hedgehog signaling in endochondral ossification. J. Dev. Biol.4, 20 (2016).

[294] Kan C, et al.. BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification. Stem Cell Res. Ther., 2019, 10: 14

[295] Karamboulas K, Dranse HJ, Underhill TM. Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFbeta signals. J. Cell Sci., 2010, 123: 2068-2076

[296] Yuasa T, et al.. Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J. Cell. Physiol., 2002, 193: 225-232

[297] Zhao M, et al.. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol. Cell. Biol., 2006, 26: 6197-6208

[298] Feltran GDS, de Andrade AF, Fernandes C, da Silva RAF, Zambuzzi WF. BMP7-induced osteoblast differentiation requires hedgehog signaling and involves nuclear mechanisms of gene expression control. Cell Biol. Int, 2024, 48: 939-950

[299] Bastida MF, Sheth R, Ros MA. A BMP-Shh negative-feedback loop restricts Shh expression during limb development. Development, 2009, 136: 3779-3789

[300] Long F, et al.. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development, 2004, 131: 1309-1318

[301] van der Horst G, Farih-Sips H, Lowik CW, Karperien M. Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells. Bone, 2003, 33: 899-910

[302] He K, et al.. Primary cilia mediate skeletogenic BMP and Hedgehog signaling in heterotopic ossification. Sci. Transl. Med., 2024, 16 eabn3486

[303] Grasser WA, et al.. BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. Int. Orthop., 2007, 31: 759-765

[304] Rico-Llanos GA, Becerra J, Visser R. Insulin-like growth factor-1 (IGF-1) enhances the osteogenic activity of bone morphogenetic protein-6 (BMP-6) in vitro and in vivo, and together have a stronger osteogenic effect than when IGF-1 is combined with BMP-2. J. Biomed. Mater. Res. A, 2017, 105: 1867-1875

[305] Yates KE, Troulis MJ, Kaban LB, Glowacki J. IGF-I, TGF-beta, and BMP-4 are expressed during distraction osteogenesis of the pig mandible. Int. J. Oral. Maxillofac. Surg., 2002, 31: 173-178

[306] Yeh LC, Ma X, Matheny RW, Adamo ML, Lee JC. Protein kinase D mediates the synergistic effects of BMP-7 and IGF-I on osteoblastic cell differentiation. Growth Factors, 2010, 28: 318-328

[307] Peng XB, Zhang Y, Wang YQ, He Q, Yu Q. IGF-1 and BMP-7 synergistically stimulate articular cartilage repairing in the rabbit knees by improving chondrogenic differentiation of bone-marrow mesenchymal stem cells. J. Cell. Biochem., 2019, 120: 5570-5582

[308] Reible, B., Schmidmaier, G., Moghaddam, A. & Westhauser, F. Insulin-like growth factor-1 as a possible alternative to bone morphogenetic protein-7 to induce osteogenic differentiation of human mesenchymal stem cells in vitro. Int. J. Mol. Sci.19, 1674 (2018).

[309] Ran G, et al.. Polypeptides IGF-1C and P24 synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells in vitro through the p38 and JNK signaling pathways. Int. J. Biochem. Cell Biol., 2021, 141 106091

[310] Wang M, Qiu Y, Gao L, Qi F, Bi L. The impact of IGF-1 on alveolar bone remodeling and BMP-2 expression in orthodontic tooth movement in diabetic rats. Adv. Clin. Exp. Med., 2023, 32: 349-356

[311] Chen L, et al.. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J. Bone, 2010, 25: 2447-2459

[312] Yin X, et al.. Autophagy in bone homeostasis and the onset of osteoporosis. Bone Res., 2019, 7: 28

[313] Ozeki N, et al.. Bone morphogenetic protein-induced cell differentiation involves Atg7 and Wnt16 sequentially in human stem cell-derived osteoblastic cells. Exp. Cell Res., 2016, 347: 24-41

[314] Zhao X, et al.. A functional autophagy pathway is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs). Am. J. Transl. Res., 2021, 13: 4233-4250

[315] Niu Z, et al.. Crosstalk between ALK3(BMPR1A) deficiency and autophagy signaling mitigates pathological bone loss in osteoporosis. Bone, 2024, 182 117052

[316] Egashira K, et al.. AMPK activation enhances osteoblast differentiation on a titanium disc via autophagy. Int. J. Implant Dent., 2024, 10 2

[317] Coculo L, et al.. Interplay between ALK2(R206H) mutant receptor and autophagy signaling regulates receptor stability and its chondrogenic functions. Cell Death Discov., 2025, 11: 117

[318] Zheng W, et al.. BMP9 promotes osteogenic differentiation of SMSCs by activating the JNK/Smad2/3 signaling pathway. J. Cell. Biochem., 2020, 121: 2851-2863

[319] Moore ER, et al.. A periosteum-derived cell line to study the role of BMP/TGFbeta signaling in periosteal cell behavior and function. Front. Physiol., 2023, 14 1221152

[320] Asparuhova MB, Caballe-Serrano J, Buser D, Chappuis V. Bone-conditioned medium contributes to initiation and progression of osteogenesis by exhibiting synergistic TGF-beta1/BMP-2 activity. Int. J. Oral Sci., 2018, 10: 20

[321] Wang Y, et al.. Synergistic effects of overexpression of BMP‑2 and TGF‑beta3 on osteogenic differentiation of bone marrow mesenchymal stem cells. Mol. Med. Rep., 2016, 14: 5514-5520

[322] Taday, R. et al. BMP-2-driven osteogenesis: a comparative analysis of porcine BMSCs and ASCs and the role of TGF-beta and FGF signaling. Biology14, 610 (2025).

[323] Zhao C, et al.. BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-beta signaling. EMBO Mol. Med., 2025, 17: 112-128

[324] Li Y, Liu Y, Guo Q. Silk fibroin hydrogel scaffolds incorporated with chitosan nanoparticles repair articular cartilage defects by regulating TGF-beta1 and BMP-2. Arthritis Res. Ther., 2021, 23: 50

[325] Ferreira CL, et al.. TGF-beta1 and BMP-4 carried by liposomes enhance the healing process in alveolar bone. Arch. Oral Biol., 2013, 58: 646-656

[326] Re’em T, Witte F, Willbold E, Ruvinov E, Cohen S. Simultaneous regeneration of articular cartilage and subchondral bone induced by spatially presented TGF-beta and BMP-4 in a bilayer affinity binding system. Acta Biomater., 2012, 8: 3283-3293

[327] Shen B, Wei A, Tao H, Diwan AD, Ma DD. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng. Part A, 2009, 15: 1311-1320

[328] Jiang F, et al.. Regulating macrophage-MSC interaction to optimize BMP-2-induced osteogenesis in the local microenvironment. Bioact. Mater., 2023, 25: 307-318

[329] Legendre F, et al.. Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-beta1, hypoxia, and COL1A1/HtrA1 siRNAs. Sci. Rep., 2017, 7 3406

[330] Hara Y, et al.. Delayed expression of circulating TGF-beta1 and BMP-2 levels in human nonunion long bone fracture healing. J. Nippon Med. Sch., 2017, 84: 12-18

[331] Anastasi, C. et al. BMP-1 disrupts cell adhesion and enhances TGF-beta activation through cleavage of the matricellular protein thrombospondin-1. Sci. Signal.13, eaba3880 (2020).

[332] Yahiro Y, et al.. PEG10 counteracts signaling pathways of TGF-beta and BMP to regulate growth, motility and invasion of SW1353 chondrosarcoma cells. J. Bone, 2019, 37: 441-454

[333] Anderson HC, Hodges PT, Aguilera XM, Missana L, Moylan PE. Bone morphogenetic protein (BMP) localization in developing human and rat growth plate, metaphysis, epiphysis, and articular cartilage. J. Histochem. Cytochem., 2000, 48: 1493-1502

[334] Yazaki Y, et al.. Immunohistochemical localization of bone morphogenetic proteins and the receptors in epiphyseal growth plate. Anticancer Res., 1998, 18: 2339-2344

[335] Garrison P, Yue S, Hanson J, Baron J, Lui JC. Spatial regulation of bone morphogenetic proteins (BMPs) in postnatal articular and growth plate cartilage. PLoS, 2017, 12: e0176752

[336] Schmal H, et al.. Immunohistological localization of BMP-2, BMP-7, and their receptors in knee joints with focal cartilage lesions. Sci. World J., 2012, 2012 467892

[337] Murtaugh LC, Chyung JH, Lassar AB. Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling. Genes Dev., 1999, 13: 225-237

[338] Erickson DM, et al.. Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner. J. Orthop. Res., 1997, 15: 371-380

[339] Lee SY, Abel ED, Long F. Glucose metabolism induced by Bmp signaling is essential for murine skeletal development. Nat. Commun., 2018, 9 4831

[340] Yoon BS, et al.. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA, 2005, 102: 5062-5067

[341] Yoon BS, et al.. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development, 2006, 133: 4667-4678

[342] Kobayashi T, Lyons KM, McMahon AP, Kronenberg HM. BMP signaling stimulates cellular differentiation at multiple steps during cartilage development. Proc. Natl. Acad. Sci. USA, 2005, 102: 18023-18027

[343] Wang Y, Zheng Y, Chen D, Chen Y. Enhanced BMP signaling prevents degeneration and leads to endochondral ossification of Meckel’s cartilage in mice. Dev. Biol., 2013, 381: 301-311

[344] Iwai T, Murai J, Yoshikawa H, Tsumaki N. Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways. J. Biol. Chem., 2008, 283: 27154-27164

[345] Li B, et al.. Gli1 labels progenitors during chondrogenesis in postnatal mice. EMBO Rep., 2024, 25: 1773-1791

[346] Mori-Akiyama Y, Akiyama H, Rowitch DH, de Crombrugghe B. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc. Natl. Acad. Sci. USA, 2003, 100: 9360-9365

[347] Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 2002, 16: 2813-2828

[348] Pathi S, Rutenberg JB, Johnson RL, Vortkamp A. Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation. Dev. Biol., 1999, 209: 239-253

[349] Kozhemyakina E, Lassar AB, Zelzer E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development, 2015, 142: 817-831

[350] Haseeb, A. et al. SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation/osteoblastic redifferentiation. Proc. Natl. Acad. Sci. USA118, e2019152118 (2021).

[351] Villiger PM, Lotz M. Differential expression of TGF beta isoforms by human articular chondrocytes in response to growth factors. J. Cell. Physiol., 1992, 151: 318-325

[352] Ballock RT, et al.. TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev. Biol., 1993, 158: 414-429

[353] Blanco FJ, Geng Y, Lotz M. Differentiation-dependent effects of IL-1 and TGF-beta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J. Immunol., 1995, 154: 4018-4026

[354] Zhou Z, et al.. Comparative transcriptome analysis provides insight into the molecular targets and signaling pathways of deer TGF-1 regulating chondrocytes proliferation and differentiation. Mol. Biol. Rep., 2023, 50: 3155-3166

[355] Boumediene K, et al.. Modulation of rabbit articular chondrocyte (RAC) proliferation by TGF-beta isoforms. Cell Prolif., 1995, 28: 221-234

[356] Zerath E, et al.. TGF-beta2 prevents the impaired chondrocyte proliferation induced by unloading in growth plates of young rats. Life Sci., 1997, 61: 2397-2406

[357] Glansbeek HL, van der Kraan PM, Vitters EL, van den Berg WB. Correlation of the size of type II transforming growth factor beta (TGF-beta) receptor with TGF-beta responses of isolated bovine articular chondrocytes. Ann. Rheum. Dis., 1993, 52: 812-816

[358] Koosha, E. et al. Proteoglycan inhibition of canonical BMP-dependent cartilage maturation delays endochondral ossification. Development151, dev201716 (2024).

[359] Serra R, et al.. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell Biol., 1997, 139: 541-552

[360] Ferguson CM, et al.. Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Endocrinology, 2000, 141: 4728-4735

[361] Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J. Biol. Chem., 2005, 280: 8343-8350

[362] Alvarez J, Serra R. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture. Dev. Dyn., 2004, 230: 685-699

[363] Cai L, et al.. TGF-beta3 enhances cell-to-cell communication in chondrocytes via the ALK5/p-Smad3 axis. Biochem. Biophys. Res. Commun., 2022, 636: 64-74

[364] Minina E, et al.. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development, 2001, 128: 4523-4534

[365] Kameda T, Koike C, Saitoh K, Kuroiwa A, Iba H. Developmental patterning in chondrocytic cultures by morphogenic gradients: BMP induces expression of indian hedgehog and noggin. Genes Cells, 1999, 4: 175-184

[366] Serra R, Karaplis A, Sohn P. Parathyroid hormone-related peptide (PTHrP)-dependent and -independent effects of transforming growth factor beta (TGF-beta) on endochondral bone formation. J. Cell Biol., 1999, 145: 783-794

[367] Li J, et al.. MEK/ERK and p38 MAPK regulate chondrogenesis of rat bone marrow mesenchymal stem cells through delicate interaction with TGF-beta1/Smads pathway. Cell Prolif., 2010, 43: 333-343

[368] Dabovic B, et al.. Bone defects in latent TGF-beta binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-beta presentation. J. Endocrinol., 2002, 175: 129-141

[369] Alvarez J, Horton J, Sohn P, Serra R. The perichondrium plays an important role in mediating the effects of TGF-beta1 on endochondral bone formation. Dev. Dyn., 2001, 221: 311-321

[370] Joo A, et al.. Sprouty2 regulates endochondral bone formation by modulation of RTK and BMP signaling. Bone, 2016, 88: 170-179

[371] Zhang D, et al.. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J. Bone, 2003, 18: 1593-1604

[372] Hanada K, et al.. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J. Cell. Biochem., 2001, 81: 284-294

[373] Zehentner BK, Dony C, Burtscher H. The transcription factor Sox9 is involved in BMP-2 signaling. J. Bone, 1999, 14: 1734-1741

[374] Clark CA, et al.. Prostaglandin E2 inhibits BMP signaling and delays chondrocyte maturation. J. Orthop. Res., 2009, 27: 785-792

[375] Zeng L, Kempf H, Murtaugh LC, Sato ME, Lassar AB. Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev., 2002, 16: 1990-2005

[376] van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthr. Cartil., 1998, 6: 306-317

[377] Li TF, et al.. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J. Bone, 2006, 21: 4-16

[378] Uusitalo H, et al.. Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J. Bone, 2001, 16: 1837-1845

[379] Harland RM. A protein scaffold plays matchmaker for chordin. Cell, 2008, 134: 718-719

[380] Gajos-Michniewicz, A., Piastowska, A. W., Russell, J. A. & Ochedalski, T. Follistatin as a potent regulator of bone metabolism. Biomarkers15, 563–574 (2010).

[381] Lim DA, et al.. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron, 2000, 28: 713-726

[382] Tatsinkam AJ, et al.. The binding of the bone morphogenetic protein antagonist gremlin to kidney heparan sulfate: Such binding is not essential for BMP antagonism. Int. J. Biochem. Cell Biol., 2017, 83: 39-46

[383] Rosen V. BMP and BMP inhibitors in bone. Ann. N. Y Acad. Sci, 2006, 1068: 19-25

[384] Wang YW, Lin WY, Wu FJ, Luo CW. Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-beta superfamily signaling module in bone and osteoporosis. Cell Commun. Signal., 2022, 20 190

[385] Emig, A. A. et al. Temporal dynamics of BMP/Nodal ratio drive tissue-specific gastrulation morphogenesis. Development. https://doi.org/10.1242/dev.202931 (2025).

[386] Groppe J, et al.. Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein. J. Bone Jt. Surg. Am., 2003, 85(A Suppl 3): 52-58

[387] Groppe J, et al.. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature, 2002, 420: 636-642

[388] Devlin RD, et al.. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology, 2003, 144: 1972-1978

[389] Wu XB, et al.. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin., 2003, 112: 924-934

[390] Secondini C, Wetterwald A, Schwaninger R, Thalmann GN, Cecchini MG. The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis. PLoS, 2011, 6: e16078

[391] Zhang D, et al.. A role for the BMP antagonist chordin in endochondral ossification. J. Bone, 2002, 17: 293-300

[392] Grall E, et al.. Self-organized BMP signaling dynamics underlie the development and evolution of digit segmentation patterns in birds and mammals. Proc. Natl. Acad. Sci. USA, 2024, 121 e2304470121

[393] Fiebig JE, et al.. The clip-segment of the von Willebrand domain 1 of the BMP modulator protein Crossveinless 2 is preformed. Molecules, 2013, 18: 11658-11682

[394] Levine AJ, Levine ZJ, Brivanlou AH. GDF3 is a BMP inhibitor that can activate Nodal signaling only at very high doses. Dev. Biol., 2009, 325: 43-48

[395] Nakayama N, et al.. A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage. Development, 2004, 131: 229-240

[396] Gooding S, Leedham SJ. Gremlin 1 - small protein, big impact: the multiorgan consequences of disrupted BMP antagonism(dagger). J. Pathol., 2020, 251: 349-352

[397] Nolan K, et al.. Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism. Cell Rep., 2016, 16: 2077-2086

[398] Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr. Opin. Cell Biol., 2007, 19: 176-184

[399] Zhao M, et al.. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J. Biol. Chem., 2004, 279: 12854-12859

[400] Yamashita M, et al.. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell, 2005, 121: 101-113

[401] Cao Y, et al.. Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation. Sci. Rep., 2014, 4 4965

[402] Li H, et al.. VCP/p97 increases BMP signaling by accelerating ubiquitin ligase Smurf1 degradation. FASEB J., 2019, 33: 2928-2943

[403] Bonni S, et al.. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat. Cell Biol., 2001, 3: 587-595

[404] Wu Q, et al.. Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum., 2008, 58: 3132-3144

[405] Murakami K, Etlinger JD. Role of SMURF1 ubiquitin ligase in BMP receptor trafficking and signaling. Cell. Signal., 2019, 54: 139-149

[406] Wang L, et al.. Molecular mechanism of the negative regulation of Smad1/5 protein by carboxyl terminus of Hsc70-interacting protein (CHIP). J. Biol. Chem., 2011, 286: 15883-15894

[407] Cui Y, et al.. SCFFBXL(1)(5) regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1. EMBO J., 2011, 30: 2675-2689

[408] Xia L, et al.. The Fused/Smurf complex controls the fate of Drosophila germline stem cells by generating a gradient BMP response. Cell, 2010, 143: 978-990

[409] Sun X, et al.. TGF-beta inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling. J. Cell. Physiol., 2018, 233: 596-606

[410] Zhu B, Xue F, Zhang C, Li G. LMCD1 promotes osteogenic differentiation of human bone marrow stem cells by regulating BMP signaling. Cell Death Dis., 2019, 10 647

[411] Kavsak P, et al.. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell, 2000, 6: 1365-1375

[412] Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 113: 685-700

[413] Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol. Biol. Cell, 2003, 14: 2809-2817

[414] Xing L, Zhang M, Chen D. Smurf control in bone cells. J. Cell. Biochem., 2010, 110: 554-563

[415] Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone, 2002, 31: 303-312

[416] Horiki M, et al.. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J. Cell Biol., 2004, 165: 433-445

[417] Sakata-Goto T, et al.. Id2 controls chondrogenesis acting downstream of BMP signaling during maxillary morphogenesis. Bone, 2012, 50: 69-78

[418] Zhang S, et al.. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol. Cell. Biol., 2007, 27: 4488-4499

[419] Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science, 1999, 286: 771-774

[420] Wu JW, et al.. Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell, 2002, 111: 357-367

[421] Loh, H. Y. et al. Post-transcriptional regulatory crosstalk between MicroRNAs and canonical TGF-beta/BMP signalling cascades on osteoblast lineage: a comprehensive review. Int. J. Mol. Sci.24, 6423 (2023).

[422] Du G, et al.. TGF-beta induced key genes of osteogenic and adipogenic differentiation in human mesenchymal stem cells and MiRNA-mRNA regulatory networks. Front. Genet., 2021, 12 759596

[423] Li H, et al.. MiRNA-10b reciprocally stimulates osteogenesis and inhibits adipogenesis partly through the TGF-beta/SMAD2 signaling pathway. Aging Dis., 2018, 9: 1058-1073

[424] Manochantr S, et al.. The effects of BMP-2, miR-31, miR-106a, and miR-148a on osteogenic differentiation of MSCs derived from amnion in comparison with MSCs derived from the bone marrow. Stem Cells Int., 2017, 2017 7257628

[425] Su X, et al.. MiR-26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway. Cell Death Dis., 2015, 6 e1851

[426] Kang H, et al.. Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway. J. Biol. Chem., 2012, 287: 38656-38664

[427] Li KC, et al.. Improved calvarial bone repair by hASCs engineered with Cre/loxP-based baculovirus conferring prolonged BMP-2 and MiR-148b co-expression. J. Tissue Eng. Regen. Med., 2017, 11: 3068-3077

[428] Qin W, et al.. Mir-494 inhibits osteoblast differentiation by regulating BMP signaling in simulated microgravity. Endocrine, 2019, 65: 426-439

[429] Garcia J, Delany AM. MicroRNAs regulating TGFbeta and BMP signaling in the osteoblast lineage. Bone, 2021, 143 115791

[430] Ye, L. C. et al. Overexpression of miR-195-5p reduces osteoporosis through activating BMP-2/SMAD/Akt/RUNX2 pathway via targeting SMURF1. J. Biol. Regul. Homeost. Agents35 (2021).

[431] Hadjimichael C, Nikolaou C, Papamatheakis J, Kretsovali A. MicroRNAs for fine-tuning of mouse embryonic stem cell fate decision through regulation of TGF-beta signaling. Stem Cell Rep., 2016, 6: 292-301

[432] Cao Z, et al.. miR-296-5p inhibits IL-1beta-induced apoptosis and cartilage degradation in human chondrocytes by directly targeting TGF-beta1/CTGF/p38MAPK pathway. Cell Cycle, 2020, 19: 1443-1453

[433] Gao H, Wang X. Serum miRNA-142 and BMP-2 are markers of recovery following hip replacement surgery for femoral neck fracture. Exp. Ther. Med., 2020, 20: 105

[434] Zhang XF, et al.. TGF-beta1-triggered BMI1 and SMAD2 cooperatively regulate miR-191 to modulate bone formation. Mol. Ther. Nucleic Acids, 2024, 35 102164

[435] Huang X, et al.. Histone deacetylase1 promotes TGF-beta1-mediated early chondrogenesis through down-regulating canonical Wnt signaling. Biochem. Biophys. Res. Commun., 2014, 453: 810-816

[436] Pei M, Chen D, Li J, Wei L. Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy. Differentiation, 2009, 78: 260-268

[437] Jeon EJ, et al.. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem., 2006, 281: 16502-16511

[438] Simonsson M, Heldin CH, Ericsson J, Gronroos E. The balance between acetylation and deacetylation controls Smad7 stability. J. Biol. Chem., 2005, 280: 21797-21803

[439] Gronroos E, Hellman U, Heldin CH, Ericsson J. Control of Smad7 stability by competition between acetylation and ubiquitination. Mol. Cell, 2002, 10: 483-493

[440] Delgado-Calle J, et al.. Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage. Bone, 2011, 49: 830-838

[441] Papathanasiou I, Kostopoulou F, Malizos KN, Tsezou A. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter. Arthritis Res. Ther., 2015, 17: 160

[442] He J, Cao W, Azeem I, Shao Z. Epigenetics of osteoarthritis: histones and TGF-beta1. Clin. Chim. Acta, 2020, 510: 593-598

[443] Jun JH, et al.. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J. Biol. Chem., 2010, 285: 36410-36419

[444] Choo MK, Yeo H, Zayzafoon M. NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone, 2009, 45: 579-589

[445] Chan NT, et al.. CTR9 drives osteochondral lineage differentiation of human mesenchymal stem cells via epigenetic regulation of BMP-2 signaling. Sci. Adv., 2022, 8 eadc9222

[446] Ideno H, et al.. G9a is involved in the regulation of cranial bone formation through activation of Runx2 function during development. Bone, 2020, 137 115332

[447] Hu L, et al.. Histone methyltransferase SETDB1 promotes osteogenic differentiation in osteoporosis by activating OTX2-mediated BMP-Smad and Wnt/beta-catenin pathways. Hum. Cell, 2023, 36: 1373-1388

[448] He Q, et al.. TGF-beta1-induced bone marrow mesenchymal stem cells (BMSCs) migration via histone demethylase KDM6B mediated inhibition of methylation marker H3K27me3. Cell Death Discov., 2022, 8: 339

[449] Wu J, et al.. Arginine methylation of R81 in Smad6 confines BMP-induced Smad1 signaling. J. Biol. Chem., 2021, 296 100496

[450] Huang H, Dou L, Song J, Luo J. CBFA2T2 is required for BMP-2-induced osteogenic differentiation of mesenchymal stem cells. Biochem. Biophys. Res. Commun., 2018, 496: 1095-1101

[451] Khalid AB, et al.. GATA4 directly regulates Runx2 expression and osteoblast differentiation. JBMR Plus, 2018, 2: 81-91

[452] Ye H, Cao L, Jackson-Weaver O, Zheng L, Gou Y. PRMT1-mediated arginine methylation promotes postnatal calvaria bone formation through BMP-Smad signaling. Bone, 2023, 176 116887

[453] Ueharu H, et al.. Augmentation of BMP signaling in cranial neural crest cells leads to premature cranial sutures fusion through endochondral ossification in mice. JBMR Plus, 2023, 7 e10716

[454] Timberlake AT, et al.. De novo mutations in the BMP signaling pathway in lambdoid craniosynostosis. Hum. Genet., 2023, 142: 21-32

[455] Kaplan FS, Pignolo RJ, Shore EM. The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev., 2009, 20: 399-407

[456] Wentworth KL, et al.. Functional testing of bone morphogenetic protein (BMP) pathway variants identified on whole-exome sequencing in a patient with delayed-onset fibrodysplasia ossificans progressiva (FOP) using ACVR1(R206H)-specific human cellular and zebrafish models. J. Bone, 2022, 37: 2058-2076

[457] Dinther M, et al.. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. J. Bone, 2010, 25: 1208-1215

[458] Hatsell SJ, et al.. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci. Transl. Med., 2015, 7: 303ra137

[459] Katagiri T. [Genetic basis for skeletal disease. Establishment of novel treatments for fibrodysplasia ossificans progressiva (FOP)]. Clin. Calcium, 2010, 20: 1204-1211

[460] Pignolo RJ, et al.. Palovarotene for fibrodysplasia ossificans progressiva (FOP): results of a randomized, placebo-controlled, double-blind phase 2 trial. J. Bone, 2022, 37: 1891-1902

[461] Davis AJ, et al.. An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. Sci. Transl. Med., 2024, 16 eabp8334

[462] Williams, E. et al. Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva. JCI Insight6, e95042 (2021).

[463] Shaikh U, et al.. Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future Directions. Cureus, 2023, 15: e42614

[464] Collins, M. T. Twists in the fibrodysplasia ossificans progressiva story challenge and expand our understanding of BMP biology. J. Clin. Invest.132, e160773 (2022).

[465] Hino K, et al.. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. J. Clin., 2017, 127: 3339-3352

[466] Kaplan FS, et al.. Acute and chronic rapamycin use in patients with fibrodysplasia ossificans progressiva: a report of two cases. Bone, 2018, 109: 281-284

[467] Valer JA, et al.. Inhibition of phosphatidylinositol 3-kinase alpha (PI3Kalpha) prevents heterotopic ossification. EMBO Mol. Med., 2019, 11 e10567

[468] Kjaer KW, et al.. A mutation in the receptor binding site of GDF5 causes Mohr-Wriedt brachydactyly type A2. J. Med. Genet., 2006, 43: 225-231

[469] Lehmann K, et al.. A novel R486Q mutation in BMPR1B resulting in either a brachydactyly type C/symphalangism-like phenotype or brachydactyly type A2. Eur. J. Hum. Genet., 2006, 14: 1248-1254

[470] Ploger F, et al.. Brachydactyly type A2 associated with a defect in proGDF5 processing. Hum. Mol. Genet., 2008, 17: 1222-1233

[471] Seemann P, et al.. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J. Clin., 2005, 115: 2373-2381

[472] Liu X, et al.. Identification of duplication downstream of BMP2 in a Chinese family with brachydactyly type A2 (BDA2). PLoS, 2014, 9: e94201

[473] Dathe K, et al.. Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am. J. Hum. Genet., 2009, 84: 483-492

[474] Seemann P, et al.. Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PLoS Genet., 2009, 5: e1000747

[475] Wang WB, et al.. A novel duplication downstream of BMP2 in a Chinese family with Brachydactyly type A2 (BDA2). Gene, 2018, 642: 110-115

[476] Lehmann K, et al.. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am. J. Hum. Genet., 2007, 81: 388-396

[477] Nakamura Y, et al.. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling. J. Clin., 2007, 117: 3075-3086

[478] Yao Y, Wang X, Lin L, Zhang X, Wang Y. ROR2-related skeletal dysplasia reveals disrupted chondrocyte polarity through modulation of BMP/TGF-beta signaling. Aging Dis., 2024, 15: 282-294

[479] Kashima R, et al.. Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome. Sci. Signal., 2016, 9: ra58

[480] Wu S, et al.. A novel mutation of TGF beta1 in a Chinese family with Camurati-Engelmann disease. Bone, 2007, 40: 1630-1634

[481] Campos-Xavier B, et al.. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum. Genet., 2001, 109: 653-658

[482] Wang X, et al.. Aberrant TGF-beta activation in bone tendon insertion induces enthesopathy-like disease. J. Clin., 2018, 128: 846-860

[483] Qin Y, et al.. Bone-targeted delivery of TGF-beta type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease. Ann. N. Y. Acad. Sci., 2018, 1433: 29-40

[484] Dewan AK, et al.. Dysregulated TGF-beta signaling alters bone microstructure in a mouse model of Loeys-Dietz syndrome. J. Orthop. Res., 2015, 33: 1447-1454

[485] Dietz, H. FBN1-related Marfan syndrome. In GeneReviews® [Internet] (eds Adam, M. P. et al.) (2001).

[486] Sedes L, et al.. Fibrillin-1 deficiency in the outer perichondrium causes longitudinal bone overgrowth in mice with Marfan syndrome. Hum. Mol. Genet., 2022, 31: 3281-3289

[487] Greene B, et al.. Inhibition of TGF-beta increases bone volume and strength in a mouse model of osteogenesis imperfecta. JBMR Plus, 2021, 5 e10530

[488] Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am. J. Hum. Genet., 2004, 75: 106-111

[489] Robert, F. et al. Disrupted BMP-9 signaling impairs pulmonary vascular integrity in hepatopulmonary syndrome. Am. J. Respir. Crit. Care Med.210, 648–661 (2024).

[490] Upton PD, Dunmore BJ, Li W, Morrell NW. An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension. Dev. Dyn., 2023, 252: 327-342

[491] Lane KB, et al.. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat. Genet., 2000, 26: 81-84

[492] Guemes M, et al.. GATA4 is essential for bone mineralization via ERalpha and TGFbeta/BMP pathways. J. Bone, 2014, 29: 2676-2687

[493] Donoso O, Pino AM, Seitz G, Osses N, Rodriguez JP. Osteoporosis-associated alteration in the signalling status of BMP-2 in human MSCs under adipogenic conditions. J. Cell. Biochem., 2015, 116: 1267-1277

[494] Poleboina S, et al.. Selenium nanoparticles stimulate osteoblast differentiation via BMP-2/MAPKs/beta-catenin pathway in diabetic osteoporosis. Nanomedicine, 2022, 17: 607-625

[495] Park SB, Park SH, Kim NH, Chung CK. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model. Spine J., 2013, 13: 1273-1280

[496] Lademann F, et al.. Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts. Commun. Biol., 2024, 7: 548

[497] Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol. Biol. Cell, 1998, 9: 1903-1918

[498] van Zoelen EJ, Duarte I, Hendriks JM, van der Woning SP. TGFbeta-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation. Stem Cell Res. Ther., 2016, 7: 123

[499] Ciardiello D, Elez E, Tabernero J, Seoane J. Clinical development of therapies targeting TGFbeta: current knowledge and future perspectives. Ann. Oncol., 2020, 31: 1336-1349

[500] Filvaroff E, et al.. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development, 1999, 126: 4267-4279

[501] Grainger DJ, Percival J, Chiano M, Spector TD. The role of serum TGF-beta isoforms as potential markers of osteoporosis. Osteoporos. Int., 1999, 9: 398-404

[502] Tural, S. et al. Association between osteoporosis and polymorphisms of the IL-10 and TGF-beta genes in Turkish postmenopausal women. Hum. Immunol.74, 1179–1183 (2013).

[503] Cong Y, Ru JY, Bao NR, Guo T, Zhao JN. A single nucleotide polymorphism in the TGF-beta1 gene (rs1982073 C>T) may contribute to increased risks of bone fracture, osteoporosis, and osteoarthritis: a meta-analysis. Clin. Rheumatol., 2016, 35: 973-985

[504] Xu J, et al.. High-Dose TGF-beta1 Impairs Mesenchymal Stem Cell-Mediated Bone Regeneration via Bmp2 Inhibition. J. Bone, 2020, 35: 167-180

[505] Zhao H, Yang M, Liu Y, Tu X, Shao G. BMP9 attenuates microgravity-related disuse osteoporosis by modulating TGFbeta and BMP signaling. npj Microgravity, 2025, 11 50

[506] Blaney Davidson EN, et al.. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res. Ther., 2007, 9 R102

[507] Pester JK, et al.. BMP-2 shows characteristic extracellular patterns in osteoarthritic cartilage: a preliminary report. GMS Interdiscip. Plast. Reconstr. Surg. DGPW, 2013, 2: Doc09

[508] Chien, S. Y. et al. Noggin inhibits IL-1beta and BMP-2 expression, and attenuates cartilage degeneration and subchondral bone destruction in experimental osteoarthritis. Cells9, 927 (2020).

[509] Chae, D. S., Han, S., Lee, M. K. & Kim, S. W. BMP-2 genome-edited human MSCs protect against cartilage degeneration via suppression of IL-34 in collagen-induced arthritis. Int. J. Mol. Sci.24, 8223 (2023).

[510] Perez-Lozano, M. L. et al. Gremlin-1 and BMP-4 overexpressed in osteoarthritis drive an osteochondral-remodeling program in osteoblasts and hypertrophic chondrocytes. Int. J. Mol. Sci.23, 2084 (2022).

[511] Sun W, Qu S, Ji M, Sun Y, Hu B. BMP-7 modified exosomes derived from synovial mesenchymal stem cells attenuate osteoarthritis by M2 polarization of macrophages. Heliyon, 2023, 9 e19934

[512] Wiesli MG, et al.. Immunomodulation using BMP-7 and IL-10 to enhance the mineralization capacity of bone progenitor cells in a fracture hematoma-like environment. Adv. Healthc. Mater, 2025, 14: e2400077

[513] Schmal H, et al.. Expression of BMP-receptor type 1A correlates with progress of osteoarthritis in human knee joints with focal cartilage lesions. Cytotherapy, 2012, 14: 868-876

[514] Jaswal AP, et al.. BMP signaling: a significant player and therapeutic target for osteoarthritis. Osteoarthr. Cartil., 2023, 31: 1454-1468

[515] Lyons KM, Rosen V. Strengthening the case for BMP inhibition as a point of intervention for osteoarthritis. Osteoarthr. Cartil., 2023, 31: 1423-1424

[516] Zhen G, et al.. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med., 2013, 19: 704-712

[517] Du X, et al.. TGF-beta3 mediates mitochondrial dynamics through the p-Smad3/AMPK pathway. Cell Prolif., 2024, 57 e13579

[518] Thielen, N. et al. Osteoarthritis-related inflammation blocks TGF-beta’s protective effect on chondrocyte hypertrophy via (de)phosphorylation of the SMAD2/3 linker region. Int. J. Mol. Sci.22, 8124 (2021).

[519] Wang C, Shen J, Ying J, Xiao D, O’Keefe RJ. FoxO1 is a crucial mediator of TGF-beta/TAK1 signaling and protects against osteoarthritis by maintaining articular cartilage homeostasis. Proc. Natl. Acad. Sci. USA, 2020, 117: 30488-30497

[520] Che, X. et al. Cbfbeta is a novel modulator against osteoarthritis by maintaining articular cartilage homeostasis through TGF-beta signaling. Cells12, 1064 (2023).

[521] Wang T, et al.. Physiologic doses of TGF-β improve the composition of engineered articular cartilage. Tissue Eng Part A, 2025, 31: 56-28

[522] Jing Z, et al.. Engineered extracellular vesicle-delivered TGF-beta inhibitor for attenuating osteoarthritis by targeting subchondral bone. J. Tissue Eng., 2024, 15 20417314241257781

[523] Schrenker S, et al.. In vivo rAAV-mediated human TGF-beta overexpression reduces perifocal osteoarthritis and improves osteochondral repair in a large animal model at one year. Osteoarthr. Cartil., 2023, 31: 467-481

[524] Sousa EB, Moura Neto V, Aguiar DP. BMP-4, TGF-beta and Smad3 as modulators of synovial fluid cells viability. Rev. Bras. Ortop., 2022, 57: 314-320

[525] Wiegertjes R, et al.. TGF-beta dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression. Osteoarthr. Cartil., 2019, 27: 1197-1207

[526] Blaney Davidson EN, et al.. TGF-beta is a potent inducer of Nerve Growth Factor in articular cartilage via the ALK5-Smad2/3 pathway. Potential role in OA related pain?. Osteoarthr. Cartil., 2015, 23: 478-486

[527] Thielen NGM, et al.. Separating friend from foe: Inhibition of TGF-beta-induced detrimental SMAD1/5/9 phosphorylation while maintaining protective SMAD2/3 signaling in OA chondrocytes. Osteoarthr. Cartil., 2023, 31: 1481-1490

[528] Garrison, K. R. et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst. Rev.2010, CD006950 (2010).

[529] Kanakaris NK, Mallina R, Calori GM, Kontakis G, Giannoudis PV. Use of bone morphogenetic proteins in arthrodesis: clinical results. Injury, 2009, 40: S62-66

[530] Mathew S, Davies M, Lund R, Saab G, Hruska KA. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur. J. Clin. Investig., 2006, 36: 43-50

[531] Zeisberg M, Kalluri R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr. Nephrol., 2008, 23: 1395-1398

[532] Moghaddam A, Elleser C, Biglari B, Wentzensen A, Zimmermann G. Clinical application of BMP 7 in long bone non-unions. Arch. Orthop. Trauma Surg., 2010, 130: 71-76

[533] Park, J. H., Koh, E. B., Seo, Y. J., Oh, H. S. & Byun, J. H. BMP-9 Improves the osteogenic differentiation ability over BMP-2 through p53 signaling in vitro in human periosteum-derived cells. Int. J. Mol. Sci.24, 15252 (2023).

[534] Fan J, et al.. Complementary modulation of BMP signaling improves bone healing efficiency. Biomaterials, 2023, 302 122335

[535] Cakmak AS, Fuerkaiti S, Karaguzel D, Karaaslan C, Gumusderelioglu M. Enhanced osteogenic potential of noggin knockout C2C12 cells on BMP-2 releasing silk scaffolds. ACS Biomater. Sci. Eng., 2023, 9: 6175-6185

[536] Jee, H. K., Jeon, W. Y., Kwak, H. W. & Seok, H. Long-term changes in adipose tissue in the newly formed bone induced by recombinant human BMP-2 in vivo. Biomimetics8, 33 (2023).

[537] Zhou L, Wang J, Mu W. BMP-2 promotes fracture healing by facilitating osteoblast differentiation and bone defect osteogenesis. Am. J. Transl. Res., 2023, 15: 6751-6759

[538] Yoon SJ, Kim SH, Choi JW, Chun HJ, Yang DH. Guided cortical and cancellous bone formation using a minimally invasive technique of BMSC- and BMP-2-laden visible light-cured carboxymethyl chitosan hydrogels. Int. J. Biol. Macromol., 2023, 227: 641-653

[539] Zouani, O. F., Chollet, C., Guillotin, B. & Durrieu, M. C. Differentiation of pre-osteoblast cells on poly(ethylene terephthalate) grafted with RGD and/or BMPs mimetic peptides. Biomaterials31, 8245–8253 (2010).

[540] Fan J, et al.. Delivery of phenamil enhances BMP-2-induced osteogenic differentiation of adipose-derived stem cells and bone formation in calvarial defects. Tissue Eng. Part A, 2015, 21: 2053-2065

[541] Lu HT, et al.. Sequential deacetylation/self-gelling chitin hydrogels and scaffolds functionalized with fucoidan for enhanced BMP-2 loading and sustained release. Carbohydr. Polym., 2023, 315 121002

[542] Ma R, Su Y, Cao R, Wang K, Yang P. Enhanced osteogenic activity and bone repair ability of PLGA/MBG scaffolds doped with ZIF-8 nanoparticles loaded with BMP-2. Int. J. Nanomed., 2023, 18: 5055-5072

[543] Tong, X. et al. The paracrine effect of hyaluronic acid-treated endothelial cells promotes BMP-2-mediated osteogenesis. Bioengineering10, 1227 (2023).

[544] Kawai, M. Y. et al. bmp-2 gene-transferred skeletal muscles with needle-type electrodes as efficient and reliable biomaterials for bone regeneration. Materials17, 880 (2024).

[545] Qin B, et al.. Antisense yycF and BMP-2 co-delivery gelatin methacryloyl and carboxymethyl chitosan hydrogel composite for infective bone defects regeneration. Int. J. Biol. Macromol., 2023, 253 127233

[546] Popova AD, et al.. Osteoconductive, osteogenic, and antipathogenic plasma electrolytic oxidation coatings on titanium implants with BMP-2. ACS Appl. Mater. Interfaces, 2023, 15: 37274-37289

[547] Zhang S, et al.. Chitosan nanofibrous scaffold with graded and controlled release of ciprofloxacin and BMP-2 nanoparticles for the conception of bone regeneration. Int. J. Biol. Macromol., 2024, 254 127912

[548] Calixto RD, et al.. Effect of the secretome of mesenchymal stem cells overexpressing BMP-9 on osteoblast differentiation and bone repair. J. Cell. Physiol., 2023, 238: 2625-2637

[549] Paz, J. et al. Effect of mesenchymal stem cells overexpressing BMP-9 primed with hypoxia on BMP targets, osteoblast differentiation and bone repair. Biology12, 1147 (2023).

[550] He W, et al.. Synergistic effects of recombinant Lentiviral-mediated BMP2 and TGF-beta3 on the osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro. Cytokine, 2019, 120: 1-8

[551] Bougioukli S, et al.. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. Bone, 2016, 84: 93-103

[552] Park S, Zhao H, Urata M, Chai Y. Sutures possess strong regenerative capacity for calvarial bone injury. Stem Cells Dev., 2016, 25: 1801-1807

[553] Wilk K, et al.. Postnatal calvarial skeletal stem cells expressing PRX1 reside exclusively in the calvarial sutures and are required for bone regeneration. Stem Cell Rep., 2017, 8: 933-946

[554] Maruyama T, Jeong J, Sheu TJ, Hsu W. Stem cells of the suture mesenchyme in craniofacial bone development, repair and regeneration. Nat. Commun., 2016, 7 10526

[555] Ransom RC, et al.. Axin2-expressing cells execute regeneration after skeletal injury. Sci. Rep., 2016, 6 36524

[556] Liao J, et al.. Nf2-FAK signaling axis is critical for cranial bone ossification and regeneration. Nat. Commun., 2025, 16 2478

[557] Vural AC, et al.. Cranial bone regeneration via BMP-2 encoding mesenchymal stem cells. Artif. Cells Nanomed. Biotechnol., 2017, 45: 544-550

[558] Guo, Y. et al. BMP-IHH-mediated interplay between mesenchymal stem cells and osteoclasts supports calvarial bone homeostasis and repair. Bone Res.6, 30 (2018).

[559] Wei B, et al.. BMP-2/TGF-beta1 gene insertion into ligament-derived stem cells sheet promotes tendon-bone healing in a mouse. Biotechnol. J., 2023, 18 e2200470

[560] Sundermann J, et al.. Spatially and temporally controllable BMP-2 and TGF-beta(3) double release from polycaprolactone fiber scaffolds via chitosan-based polyelectrolyte coatings. ACS Biomater. Sci. Eng., 2024, 10: 89-98

[561] Deng M, et al.. TGFbeta3 recruits endogenous mesenchymal stem cells to initiate bone regeneration. Stem Cell Res. Ther., 2017, 8: 258

[562] Majumder N, Seit S, Bhabesh NS, Ghosh S. An advanced bioconjugation strategy for covalent tethering of TGFbeta3 with silk fibroin matrices and its implications in the chondrogenesis profile of human BMSCs and human chondrocytes: a paradigm shift in cartilage tissue engineering. Adv. Healthc. Mater., 2024, 13 e2303513

RIGHTS & PERMISSIONS

The Author(s)